Journal of labelled compounds and radiopharmaceuticals p. 229 - 235 (2006)
Update date:2022-08-03
Topics:
Oba, Makoto
Ohkuma, Kosuke
Hitokawa, Hiroshi
Shirai, Ayumi
Nishiyama, Kozaburo
Novel 3,4-didehydropyroglutamate derivatives, the key intermediates in this synthesis, were obtained from a protected pyroglutamate by the well-known selenenylation-oxidative deselenenylation method and were catalytically deuterated using a slow-addition technique. The obtained deuterated pyroglutamates were converted to [3,4-2H2]glutamic acid, [3,4,5-2H3]proline, and [3,4,5,5,5-2H 5]leucine via an appropriate functional group interconversions followed by the standard deprotection procedure. Copyright
View MoreTaizhou Shengxing Chempharm Co.,Ltd
Contact:+86-576-88516600
Address:Yantou Chemical Zone Jiaojiang Taizhou Zhejiang China
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Guangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:Suite 501,198 Kaiyuan Ave.,Science City, Guangzhou,China
Suzhou Jingye Medicine & Chemical Co., Ltd
website:http://www.jingyechem.cn
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
Doi:10.1002/anie.200600666
(2006)Doi:10.1016/j.electacta.2006.05.023
(2006)Doi:10.1007/BF00579470
(1984)Doi:10.1016/S0040-4039(01)80212-4
(1984)Doi:10.1021/ja064737l
(2006)Doi:10.1016/j.bmc.2007.08.046
(2007)